Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer

Receiving Drugs Containing Selenium Does Not Reduce The Risk Of Lung Cancer.
Taking the in demand mineral end-piece selenium doesn't slim the good chance of lung cancer recurrence, a new study reveals. Lead inventor Dr Daniel D Karp, a professor in the sphere of influence of thoracic head and neck medical oncology at the University of Texas MD Anderson Cancer Center, is scheduled to immediate the verdict Saturday at the American Society of Clinical Oncology annual meeting, in Chicago neosize xl plus. "Several epidemiological and physical studies have long-suggested a connection between deficiency of selenium and cancer development," said Karp in a announcement release.

So "Interest and research escalated in the belated 1990s after a skin cancer and selenium study, published in 1996, found no promote against the skin cancer, but did suggest an approximate 30 percent reduction of prostate and lung cancers. Our lung cancer inquiry and another biggest study for the prevention of prostate cancer evolved from that finding".